MAGEF1
Basic information
Region (hg38): 3:184710364-184712064
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAGEF1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 14 | 14 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 14 | 0 | 2 |
Variants in MAGEF1
This is a list of pathogenic ClinVar variants found in the MAGEF1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-184710982-C-G | not specified | Uncertain significance (Apr 27, 2023) | ||
3-184711068-T-A | not specified | Uncertain significance (Jan 23, 2024) | ||
3-184711098-C-T | not specified | Uncertain significance (Dec 15, 2022) | ||
3-184711103-G-A | not specified | Uncertain significance (Jul 20, 2022) | ||
3-184711173-C-A | not specified | Uncertain significance (May 24, 2023) | ||
3-184711238-C-A | not specified | Uncertain significance (Oct 14, 2023) | ||
3-184711258-C-A | not specified | Uncertain significance (Dec 01, 2022) | ||
3-184711299-C-T | not specified | Uncertain significance (Jun 17, 2024) | ||
3-184711326-T-C | not specified | Uncertain significance (Jan 23, 2024) | ||
3-184711331-C-G | not specified | Uncertain significance (Jan 11, 2023) | ||
3-184711332-C-T | not specified | Uncertain significance (Apr 23, 2024) | ||
3-184711345-A-ATCCTCC | not specified | Benign (Mar 29, 2016) | ||
3-184711401-G-A | not specified | Uncertain significance (Mar 25, 2024) | ||
3-184711428-C-G | not specified | Uncertain significance (Jun 06, 2022) | ||
3-184711494-A-C | not specified | Uncertain significance (Sep 22, 2023) | ||
3-184711607-G-A | not specified | Uncertain significance (Nov 17, 2022) | ||
3-184711613-C-G | not specified | Uncertain significance (May 29, 2024) | ||
3-184711634-G-A | not specified | Uncertain significance (May 08, 2023) | ||
3-184711720-C-G | not specified | Uncertain significance (Feb 05, 2024) | ||
3-184711769-T-TC | Benign (Dec 19, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAGEF1 | protein_coding | protein_coding | ENST00000317897 | 1 | 1681 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00301 | 0.605 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.0429 | 173 | 171 | 1.01 | 0.00000790 | 1975 |
Missense in Polyphen | 50 | 45.14 | 1.1077 | 526 | ||
Synonymous | 1.79 | 54 | 73.5 | 0.735 | 0.00000352 | 628 |
Loss of Function | 0.417 | 4 | 5.01 | 0.799 | 2.09e-7 | 80 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Enhances ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin ligases. Proposed to act through recruitment and/or stabilization of the E2 ubiquitin-conjugating enzyme at the E3:substrate complex. MAGEF1-NSMCE1 ubiquitin ligase complex promotes proteasomal degradation of MMS19, a key component of the cytosolic iron-sulfur protein assembly (CIA) machinery. Down-regulation of MMS19 impairs the activity of several DNA repair and metabolism enzymes such as ERCC2/XPD, FANCJ, RTEL1 and POLD1 that require iron-sulfur clusters as cofactors. May negatively regulate genome integrity by inhibiting homologous recombination-mediated double-strand break DNA repair (PubMed:29225034). {ECO:0000269|PubMed:20864041, ECO:0000269|PubMed:29225034}.;
Recessive Scores
- pRec
- 0.0958
Intolerance Scores
- loftool
- 0.753
- rvis_EVS
- 1.15
- rvis_percentile_EVS
- 92.47
Haploinsufficiency Scores
- pHI
- 0.0575
- hipred
- N
- hipred_score
- 0.180
- ghis
- 0.411
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0923
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- protein ubiquitination;protein maturation by iron-sulfur cluster transfer;negative regulation of double-strand break repair via homologous recombination;positive regulation of ubiquitin-dependent protein catabolic process
- Cellular component
- Molecular function
- protein binding